Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Global Lung Function Initiative
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
Centrally located lung cancer and risk of occult nodal disease: an objective evaluation of multiple definitions of tumour centrality with dedicated imaging software
Roberto F. Casal, Boris Sepesi, Ala-Eddin S. Sagar, Juerg Tschirren, Minxing Chen, Liang Li, Jennifer Sunny, Joyce Williams, Horiana B. Grosu, George A. Eapen, Carlos A. Jimenez, David E. Ost
Eur Respir J, 53 (5) 1802220; 10.1183/13993003.02220-2018
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Roberto F. Casal, Boris Sepesi, Ala-Eddin S. Sagar, Juerg Tschirren, Minxing Chen, Liang Li, Jennifer Sunny, Joyce Williams, Horiana B. Grosu, George A. Eapen, Carlos A. Jimenez, David E. Ost. Centrally located lung cancer and risk of occult nodal disease: an objective evaluation of multiple definitions of tumour centrality with dedicated imaging software. Eur Respir J, 53 (5) 1802220; 10.1183/13993003.02220-2018
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Challenges in the management of SCLC
Related content which might interest you:
Estimation of the mediastinal involvement probability in lung cancer: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy?
Source: Eur Respir J 2002; 20: Suppl. 38, 186s
Probability of malignancy based on automatic segmentation and software measurements of nodules in the Danish lung cancer screening trial (DLCST)
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease?
Source: Eur Respir J, 53 (3) 1801508; 10.1183/13993003.01508-2018
Objective measurement of tumor central location can predict nodal involvement in patients with cT1N0M0 non-small cell lung cancer
Source: Virtual Congress 2020 – Screening and early lung cancer
Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant. A prospective study
Source: Eur Respir J 2007; 30: Suppl. 51, 206s
PET-CT a useful staging tool for patients with non small lung cancer when applied based on surgeons‘ discretion as well as guidelines
Source: Annual Congress 2010 - State of the art imaging
Incidence of hidden extrathoracic metastases and unexpected second malignancies detected by PET in patients with lung cancer.
Source: International Congress 2019 – Diagnosis of lung cancer
Complete and systematic mediastinal nodal staging for lung cancer (SCORE study)>
Source: International Congress 2017 – Interventional pulmonology highlights 2017
What the radiologist can offer - the latest imaging and evaluation techniques for lung cancer screening and comorbidities
Source: International Congress 2018 – Lung cancer screening and management of solitary pulmonary nodules
Detection of unusual distant metastases or secondary malignancies in the routine staging of primary lung cancer with
Source: Annual Congress 2009 - Old and new: technique and pathology
Screening for incidence of lung cancer (LC) among the patients with pulmonary pathology (with special reference to histological subtype and TNM-staging system) in Ukraine
Source: Eur Respir J 2005; 26: Suppl. 49, 537s
An algorithm for lung cancer staging
Source: School Course 2014- Endoscopic ultrasound in the diagnosing and staging of lung cancer
Combining pulmonary and cardiac computed tomography biomarkers for disease-specific risk modelling in lung cancer screening
Source: Eur Respir J, 58 (3) 2003386; 10.1183/13993003.03386-2020
Lung metastasectomy should always be performed. The aim of new dedicated TNM staging for lung metastases
Source: Virtual Congress 2021 – Lung metastasectomy: let’s pour some water on the fire
Biological factors predicting response to chemotherapy (CT) in advanced non small cell lung cancer (NSCLC): A feasibility study on the collection of tissue
Source: Annual Congress 2010 - The role of biomarkers in lung cancer
Staging of non-small-cell lung cancer with FDG-PET/CT: Is there a correlation of morphologic tumor characteristics and metabolic activity?
Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life
Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach